Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 4
2017 7
2018 5
2019 2
2020 13
2021 6
2022 9
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Association of hypothyroidism with survival in pancreatic cancer: retrospective cohort study.
Garajová I, Comandatore A, Boyd L, Ali M, Gelsomino F, de Lorenzo S, Pedrazzi G, Spallanzani A, Martinelli G, Balsano R, Leonardi F, Palmeri M, Kazemier G, Di Franco G, Guadagni S, Furbetta N, Gentiluomo M, Ramacciotti N, Di Candio G, Giovannetti E, Morelli L. Garajová I, et al. Among authors: de lorenzo s. BJS Open. 2024 Jan 3;8(1):zrad119. doi: 10.1093/bjsopen/zrad119. BJS Open. 2024. PMID: 38195161 Free PMC article. No abstract available.
Should patients on levothyroxine therapy be screened for pancreatic cancer?
Garajova I, Balsano R, Coriano' M, Gelsomino F, Tovoli F, De Lorenzo S, Del Rio P, Dalla Valle R, Ravaioli M, Leonardi F. Garajova I, et al. Among authors: de lorenzo s. Acta Biomed. 2022 Dec 16;93(6):e2022268. doi: 10.23750/abm.v93i6.13366. Acta Biomed. 2022. PMID: 36533763 Free PMC article.
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv).
Orsi G, Cavaliere A, Tortora G, Lonardi S, Macchini M, Di Marco M, Giordano G, Vasile E, Scartozzi M, Bozzarelli S, Noventa S, Rodriquenz MG, Militello AM, Rapposelli IG, Garajova I, De Lorenzo S, Merelli B, Bittoni A, Salvatore L, Procaccio L, Paratore C, Spallanzani A, Peretti U, Niger M, Giommoni E, Bernardini I, Tamburini E, Bernardino K, Forti L, Valente MM, Cascinu S, Milella M, Reni M. Orsi G, et al. Among authors: de lorenzo s. Br J Cancer. 2023 Mar;128(5):877-885. doi: 10.1038/s41416-022-02086-w. Epub 2022 Dec 8. Br J Cancer. 2023. PMID: 36482190 Free PMC article.
Third-line chemotherapy in advanced biliary cancers (ABC): pattern of care, treatment outcome and prognostic factors from a multicenter study.
Salati M, Rizzo A, Merz V, Messina C, Francesco C, Gelsomino F, Spallanzani A, Ricci AD, Palloni A, Frega G, De Lorenzo S, Carotenuto P, Pettorelli E, Benatti S, Luppi G, Melisi D, Brandi G, Dominici M. Salati M, et al. Among authors: de lorenzo s. Expert Rev Gastroenterol Hepatol. 2022 Jan;16(1):73-79. doi: 10.1080/17474124.2022.2017772. Epub 2021 Dec 21. Expert Rev Gastroenterol Hepatol. 2022. PMID: 34890512
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma.
Tovoli F, Dadduzio V, De Lorenzo S, Rimassa L, Masi G, Iavarone M, Marra F, Garajova I, Brizzi MP, Daniele B, Trevisani F, Messina C, Di Clemente F, Pini S, Cabibbo G, Granito A, Rizzato MD, Zagonel V, Brandi G, Pressiani T, Federico P, Vivaldi C, Bergna I, Campani C, Piscaglia F. Tovoli F, et al. Among authors: de lorenzo s. Liver Cancer. 2021 Jul;10(4):370-379. doi: 10.1159/000515551. Epub 2021 Jun 15. Liver Cancer. 2021. PMID: 34414124 Free PMC article.
43 results